Recurrence Dynamics After Complete Resection and Adjuvant Chemotherapy in Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer

被引：0
|
作者：
Sun, X. [1 ]
Men, Y. [2 ]
Yang, X. [1 ]
Deng, L. [3 ]
Wang, W. [1 ]
Zhai, Y. R. [4 ]
Liu, W., Jr. [1 ]
Zhang, T. [1 ]
Wang, X. [1 ]
Bi, N. [1 ]
Lv, J. [1 ]
Liang, J. [1 ]
Feng, Q. [1 ]
Chen, D. [1 ]
Xiao, Z. [1 ]
Zhou, Z. [1 ]
Wang, L. [5 ]
Hui, Z. [1 ,2 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Canc Hosp, Dept Radiat Oncol,Natl Canc Ctr, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Canc Hosp, Dept VIP Med Serv,Natl Canc Ctr, Beijing, Peoples R China
[3] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Canc Inst & Hosp, Natl Canc Ctr, Dept Radiat Oncol, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Shenzhen Hosp, Canc Hosp, Shenzhen, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2937
引用
下载
收藏
页码：E453 / E453
页数：1
相关论文
共 50 条
  • [21] A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk Analysis
    Sun, Shuang
    Men, Yu
    Kang, Jingjing
    Sun, Xin
    Yuan, Meng
    Yang, Xu
    Bao, Yongxing
    Wang, Jianyang
    Deng, Lei
    Wang, Wenqing
    Zhai, Yirui
    Liu, Wenyang
    Zhang, Tao
    Wang, Xin
    Bi, Nan
    Lv, Jima
    Liang, Jun
    Feng, Qinfu
    Chen, Dongfu
    Xiao, Zefen
    Zhou, Zongmei
    Wang, Luhua
    Hui, Zhouguang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancer
    Selek, Ugur
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2016, 8 (07) : 1394 - 1397
  • [23] Survival determinants in patients with stage IIIa, N2 non-small cell lung cancer underwent complete resection
    Takizawa, T
    Terashima, M
    Koike, T
    Aoki, T
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 375 - 379
  • [24] RISK OF BILOBECTOMY AFTER NEOADJUVANT CONCURRENT CHEMORADIOTHERAPY FOR STAGE IIIA-N2 NON-SMALL CELL LUNG CANCER
    Cho, Jong Ho
    Kim, Hong Kwan
    Kim, Jhingook
    Choi, Yong Soo
    Kim, Kwhanmien
    Shim, Young Mog
    Park, Keunchil
    Ahn, Yong Chan
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S878 - S878
  • [25] Optimal Treatment of Stage IIIA-N2 Non-Small Cell Lung Cancer: A Neverending Story?
    Van Schil, Paul E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (09) : 1338 - 1340
  • [26] Postoperative radiotherapy in non-small cell lung cancer stage IIIA-N2: Focus and perspectives
    Wang, Pascal
    Duchemann, Boris
    Chouahnia, Kader
    Matton, Lise
    Benabadji, Ambre
    Zelek, Laurent
    Popotte, Hosni
    Paix, Adrien
    BULLETIN DU CANCER, 2023, 110 (01) : 101 - 112
  • [27] Postoperative Radiotherapy in Completely Resected Stage IIIA-N2 Non-Small Cell Lung Cancer
    Ahn, S.
    Na, K.
    Kim, Y.
    Song, S.
    Oh, I.
    Park, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2180 - S2181
  • [28] Surgery for stage IIIA-N2 non-small cell lung cancer: the jury is still out!
    Berzenji, Lawek
    Beckers, Paul
    Van Schil, Paul E.
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S1153 - S1156
  • [29] Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
    van Meerbeeck, Jan P.
    Kramer, Gijs W. P. M.
    Van Schil, Paul E. Y.
    Legrand, Catherine
    Smit, Egbert F.
    Schramel, Franz
    Tjan-Heijnen, Vivianne C.
    Biesma, Bonne
    Debruyne, Channa
    van Zandwijk, Nico
    Splinter, Ted A. W.
    Giaccone, Giuseppe
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (06): : 442 - 450
  • [30] Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
    Lopez, S.
    CANCER RADIOTHERAPIE, 2008, 12 (05): : 500 - 501
12345